Catalyst
Slingshot members are tracking this event:
Faslodex receives US FDA approval as monotherapy for expanded use in breast cancer
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AZN |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 28, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Breast Cancer, Monotherapy, Faslodex
